- ... wait policy versus immediate systemic treatment for asymptomatic advanced-stage ... IV non-Hodgkin's lymphomas of favorable histologic types. Ann Intern Med 90 (1): 10- ...
- ... wait policy versus immediate systemic treatment for asymptomatic advanced-stage ... IV non-Hodgkin's lymphomas of favorable histologic types. Ann Intern Med 90 (1): 10- ...
- ... and may have systemic symptoms, extranodal disease, and advanced-stage disease. However, they have a more favorable survival rate than patients with ALK-negative disease.[ ...
- ... accuracy of testing strategies for sub-typing aggressive non-Hodgkin's lymphomas (NHL) Burkitt lymphoma (BL) versus diffuse large B- ... testing strategies for the identification of genes in non-Hodgkin's lymphomas One study ( Chang et al , 2010 ) assessed the ...
- ... after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas. J Clin Oncol 11 (2): 239-47, 1993. [ ... chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from ...
- ... html">Hodgkin disease</a>. The rest are called non-Hodgkin lymphomas.</p> <p>Non-Hodgkin lymphomas begin when a type of white blood cell, ... in some parts of the United States more favorable to certain types of mosquitoes. Other reasons include ...
- ... Murphy SB, Fairclough DL, Hutchison RE, et al.: Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, ... starry sky pattern.[ 19 , 20 ] Outcomes appear highly favorable in the small number of cases identified.[ 19 , ...
- ... and Holly, E.A. (2004). Expert review of non-Hodgkin's lymphomas in a population-based cancer registry: reliability of ... primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related ...
- ... cells and accounts for roughly 10% of all non-Hodgkin's Lymphomas (NHL). There are a number of subtypes although ... Dabaja B, Tsang RW, Qi S, et al. Favorable outcome in stage I-II mantle cell lymphoma: ...
- ... groupings proposed by the Working Group for classifying non- Hodgkin's lymphomas. LYMPHOMA, LARGE-CELL - often called "histiocytic" LYMPHOMA, SMALL- ... is pre-planned and involves observations for predefined favorable and unfavorable effects. All FDA phases will take ...
26 results